1. Home
  2. JOUT vs LYEL Comparison

JOUT vs LYEL Comparison

Compare JOUT & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JOUT

Johnson Outdoors Inc.

HOLD

Current Price

$51.72

Market Cap

486.7M

ML Signal

HOLD

Logo Lyell Immunopharma Inc.

LYEL

Lyell Immunopharma Inc.

HOLD

Current Price

$20.09

Market Cap

556.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JOUT
LYEL
Founded
1970
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
486.7M
556.1M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
JOUT
LYEL
Price
$51.72
$20.09
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$30.60
AVG Volume (30 Days)
82.7K
65.2K
Earning Date
05-08-2026
05-13-2026
Dividend Yield
2.53%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$592,415,000.00
$36,000.00
Revenue This Year
$11.67
N/A
Revenue Next Year
$3.70
$8,712.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.53
$0.40
52 Week High
$53.54
$45.00

Technical Indicators

Market Signals
Indicator
JOUT
LYEL
Relative Strength Index (RSI) 53.47 37.04
Support Level $42.87 $15.82
Resistance Level $53.54 $27.30
Average True Range (ATR) 2.03 1.43
MACD -0.15 -0.35
Stochastic Oscillator 64.86 0.00

Price Performance

Historical Comparison
JOUT
LYEL

About JOUT Johnson Outdoors Inc.

Johnson Outdoors Inc is a manufacturer and marketer of branded seasonal, outdoor recreation products used for fishing from a boat, diving, paddling, hiking and camping. The company has four operating segment: Fishing, Camping, Watercraft Recreation, and Diving. It generates maximum revenue from the Fishing segment which produces and markets products under different brands such as Minn Kota electric motors for quiet trolling or primary propulsion, marine battery chargers and shallow water anchors; Humminbird sonar and GPS equipment for fish finding, navigation and marine cartography; and Cannon downriggers for controlled-depth fishing. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe, Canada, and other regions.

About LYEL Lyell Immunopharma Inc.

Lyell Immunopharma Inc s a late-stage clinical cell therapy company advancing a pipeline of proprietary next-generation autologous chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The Company's product candidate, rondecabtagene autoleucel (ronde-cel, also known as LYL314), is an autologous dual-targeting CD19/CD20 CAR T-cell therapy in development for large B-cell lymphoma (LBCL). The Company has recently acquired exclusive rights outside of mainland China, Hong Kong, Macau and Taiwan, to a novel guanylyl cyclase C (GCC)-targeted CAR T-cell product candidate in early clinical development for refractory metastatic colorectal cancer (mCRC) and other GCC-expressing cancers.

Share on Social Networks: